ScholarIQanswers from OpenAlex

Less Lipoatrophy and Better Lipid Profile With Abacavir as Compared to Stavudine

PaperCitations, authors & open-access status

Less Lipoatrophy and Better Lipid Profile With Abacavir as Compared to Stavudine is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Less Lipoatrophy and Better Lipid Profile With Abacavir as Compared to Stavudine have?

ScholarIQcitation count

Less Lipoatrophy and Better Lipid Profile With Abacavir as Compared to Stavudine has 137 citations in the OpenAlex counts ScholarIQ stores.

When was Less Lipoatrophy and Better Lipid Profile With Abacavir as Compared to Stavudine published?

ScholarIQyear

Less Lipoatrophy and Better Lipid Profile With Abacavir as Compared to Stavudine has 2006 year in the ScholarIQ index.

What is the open-access status of Less Lipoatrophy and Better Lipid Profile With Abacavir as Compared to Stavudine?

ScholarIQoa status

Less Lipoatrophy and Better Lipid Profile With Abacavir as Compared to Stavudine has closed oa status in the ScholarIQ index.

What is the DOI of Less Lipoatrophy and Better Lipid Profile With Abacavir as Compared to Stavudine?

ScholarIQdoi

The DOI for Less Lipoatrophy and Better Lipid Profile With Abacavir as Compared to Stavudine is on the source record.

What is the PMID of Less Lipoatrophy and Better Lipid Profile With Abacavir as Compared to Stavudine?

ScholarIQpmid

The PMID for Less Lipoatrophy and Better Lipid Profile With Abacavir as Compared to Stavudine is on the source record.

What is the OpenAlex record for Less Lipoatrophy and Better Lipid Profile With Abacavir as Compared to Stavudine?

ScholarIQopenalex

The OpenAlex for Less Lipoatrophy and Better Lipid Profile With Abacavir as Compared to Stavudine is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial